Background Many psychiatric disorders including schizophrenia, bipolar disorder and major
depression convey an excess burden of cardiovascular morbidity and mortality. The …

Antipsychotic drugs (APDs), and the 'atypical'APDs in particular, are commonly associated
with metabolic side effects in humans. These include glucose dysregulation, insulin …

Second generation antipsychotics are commonly prescribed for the treatment of
schizophrenia, however some can induce metabolic dysfunction side-effects such as weight …

Objective (s): As olanzapine has side effects such as weight gain and metabolic disorders,
and alpha-mangostin has been shown to control metabolic disorders, the effects of alpha …

The newer atypical antipsychotics, as a class, have been associated with an increased risk
of weight gain and metabolic abnormalities. The mechanisms underlying this phenomenon …

One of the best antipsychotics for treating schizophrenia and bipolar disorders is olanzapine
(OLA). However, its use is restricted owing to unfavorable adverse effects as liver damage …

Atypical antipsychotics particularly olanzapine are associated with obesity and serious
metabolic disturbances. As green tea (Camellia sinensis) is generally associated with …

The therapeutic use of atypical antipsychotics is associated with a high incidence of
metabolic side-effects. In the present study we examined the acute effects of both high and …

Second generation antipsychotic (SGA) drugs are effective treatments for psychosis.
Common side-effects of SGAs include metabolic dysregulation and risk of cardiometabolic …

The ability of clozapine to induce weight gain in female rats was investigated in three studies
with progressively lowered doses of clozapine. In an initial preliminary high dose study …